Join
Live feed
·
PRReleasevia Quantisnow
Xilio Therapeutics Inc. logo

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ByQuantisnow·Wall Street's wire, on your screen.
XLO· Xilio Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XLO (Xilio Therapeutics Inc.) and more on Quantisnow.